Novel approach for identification of left ventricle geometry in patients with chronic heart failure, AH and IHD in combination with COPD.
Dziak GV. [Effectiveness of ivabradine in pa-tients with cardiorespiratory pathology]. Ukr. Pulmonol. Zh. 2008;3(supl.):55. Russian.
Dolgusheva YA, Zikov KA, Chasova IY. [B-ago-nists different actions in patients with combined car-diovascular pathology and bronchoobstructive diseases]. Practical pulmonology. 2015;2:41-47. Russian.
Koval EA. [CHF in comorbities condition: choice of optimal b-blocker]. Health of Ukraine. 2015; 3(40):19. Russian.
[On approval and implementation of medical and technological documents on standartization of medical care in arterial hypertention: Order N 284 MoH of Ukraine]; 2012. Ukrainian.]
[On approval and implementation of medical and technological documents on standartization of medical care in stable ischemic heart disease: Order N 152 MoH of Ukraine]; 2016. Ukrainian.
[On approval and implementation of medical and technological documents on standartization of medical care in chronic obstructive pulmonary disease: Order N 555 MoH of Ukraine]; 2013. Ukrainian.]
Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009;33:1165-85.
Campo G, Guastaroba P, Marzocchi A, Santarelli A, Varani E, Vignali L, Sangiorgio P, Tondi S, Serenelli C, De Palma R, Saia F. Impact of COPD on long-term outcome after ST-segment elevation myocardial infar-ction receiving primary percutaneous coronary inter-vention. Chest. 2013;144:750-7.
Campo G, Pavasini R, Biscaglia S, Contoli M, Ceconi C. Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstruc-tive pulmonary disease. Eur. Heart J. – Cardiovasc. Pharmacother. 2015;1:205-11.
Waheed S, Chaves PHM, Gardin JM, Cao JJ. Car-diovascular and mortality outcomes in the elderly with im¬paired cardiac and pulmonary function: The Cardiovascular Health Study (CHS). J. Am. Heart Assoc. 2015;4:1-10.
Valk MJ, Broekhuizen BD, Mosterd A, Zuithoff NP, Hoes AW, Rutten FH. COPD in patients with stable heart failure in the primary care setting. Intern. J. COPD. 2015;10:1219-24.
van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, Maggioni AP, Voors AA. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur. J. Heart Failure. 2014;16:103-11.
Fisher KA. Impact of COPD on the mortality and treatment of patients hospitalized with acute decom¬pen-sated heart failure (The Worcester Heart Failure Study): A Masters Thesis. University of Massachusetts Medical School. - GSBS Dissertations and Theses; 2014. Available from: http://escholarship.umassmed.edu/gs¬bs_diss/717.
Gaasch WH, Zile MR. Left ventricular structural re¬mo¬deling in health and disease:with special emphasis on volu¬me, mass, and geometry. J.Am.Coll. Cardiol. 2011;58:1733-40.
Global Initiative for chronic obstructive lung di-sease – global strategy for the diagnosis, management and prevention for chronic obstructive pulmonary disease. Updated; 2016.
Guzik TJ, Grodzicki T. “Radical” Link Between Chronic Obstructive Pulmonary Disease and Cardiovas-cular Disease? Hypertension. 2014;63:444-6.
Wakabayashi K, Gonzalez MA, Delhaye C, Ben-Dor I, G.Maluenda G. Impact of chronic obstructive pul-monary disease on acute phase outcome of myocardial infarction. Am. J. Cardiol. 2010;106:305-9.
Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137:1091-7.
Lahousse L, Niemeijer MN, van den Berg ME. Chronic obstructive pulmonary disease and sudden car-diac death: the Rotterdam study. Eur. Heart J. doi:10.1093/eurheartj/ehv121; 2015.
Lainscak M, Anker SD. Heart failure, chronic ob-structive pulmonary disease, and asthma: numbers, facts, and challenges. ESC Heart Failure. 2015;2:1-5.
Maclay D, MacNee W. Cardiovascular disease in COPD. Chest. 2013;143:798-807.
Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65:956-62.
Recommendations for cardiac chamber quantifi-cation by echocardiography: an update from the American Society of Echocardiography and the European As¬sociation of Cardiovascular Imaging. J.Am.Soc. Echocar¬diogr. 2015;28:1–39.
Marwick TH, Gillebert TC, Aurigemma G, Chi-rinos J, Derumeaux G, Galderisi M, Gottdiener J, Haluska B, Ofili E, Segers P, Senior R, Tapp RJ, Zamorano JL. Recommendations on the use of echocardiography in adult hypertension: a report from the European Asso-ciation of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur. Heart J. - Cardiovasc. Imag. 2015;16:577-605.
Rothnie KJ, Smeeth L, Herrett E. Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease. Heart. 2015;101:1103-10.
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization. Eur. Heart J. 2014;35:2541-619.
GOST Style Citations
This work is licensed under a Creative Commons Attribution 4.0 International License